TLDR XRP price trades near $1.55-$1.60, a level not seen in nearly two years, after falling from its July 2025 peak of $3.66. The token broke out from a consolidationTLDR XRP price trades near $1.55-$1.60, a level not seen in nearly two years, after falling from its July 2025 peak of $3.66. The token broke out from a consolidation

XRP Price: Three Factors That Could Trigger a Rebound from Current Levels

4 min read

TLDR

  • XRP price trades near $1.55-$1.60, a level not seen in nearly two years, after falling from its July 2025 peak of $3.66.
  • The token broke out from a consolidation range in November 2024, surging from $0.50 to $2.00 before reaching $3.66 in July 2025.
  • XRP spot ETF assets total $1.19 billion, with inflow patterns potentially signaling support for a near-term price rebound.
  • Ripple Labs received full Electronic Money Institution approval from Luxembourg’s CSSF on February 2, 2026, expanding its EU operations.
  • White House meetings between crypto and banking representatives revealed ongoing challenges to stablecoin yield legislation and the Market Structure Bill.

XRP price dropped to levels last seen in early 2024, putting the cryptocurrency at a critical technical juncture. The token currently trades between $1.55 and $1.60 after declining from its July 2025 peak of $3.66.

xrp priceXRP Price

The current price level marks a return to the breakout zone from November 2024. For most of 2023 and early 2024, XRP traded in a tight range between $0.45 and $0.70. In November 2024, the token broke above this range, climbing from around $0.50 to $2.00 within weeks.

Between December 2024 and March 2025, XRP consolidated between $2.00 and $3.20. The token then pushed higher, reaching $3.66 in July 2025. However, multiple attempts to hold above $3.50 failed, and selling pressure increased through the second half of 2025.

The current price zone sits near the midpoint of the November 2024 breakout move. This area previously acted as resistance before becoming support. A break below current levels would expose the $1.30 to $1.35 range, with psychological support near $1.00 to $1.10 below that.

ETF Activity Shows Mixed Signals

Total net assets across XRP spot ETFs stand near $1.19 billion. Daily flows have turned uneven, with some days showing moderate inflows that suggest cautious market participation.

Previous periods of high ETF inflows coincided with XRP price consolidation or rallies. If daily inflows increase, it could help absorb selling pressure at current levels. ETF flows represent institutional buying activity separate from retail trading.

Ripple Secures European Regulatory Approval

On February 2, 2026, Ripple Labs confirmed it received full approval for an Electronic Money Institution license from Luxembourg’s financial regulator, the CSSF. This followed preliminary approval and completion of all required conditions.

The license allows Ripple to operate across the European Union under a unified framework. It builds on recent approval from the United Kingdom’s Financial Conduct Authority, where Ripple secured both an EMI license and cryptoasset registration.

Ripple now holds more than 75 regulatory licenses worldwide. This places it among the most regulated firms in the digital asset sector.

White House meetings on February 2 between banking and crypto representatives highlighted ongoing challenges to crypto legislation. Discussions focused on stablecoin yield rules. A statement from banking trade groups emphasized the need to protect the financial system and local lending.

Crypto representatives wanted to discuss specific solutions on yield. Bank trade representatives avoided details and did not discuss discrete solutions. The different approaches suggest negotiations may face obstacles.

The US Senate Banking Committee postponed a markup vote on its draft text for the Market Structure Bill. Coinbase withdrew support, stating the draft text eliminated rewards on stablecoins.

XRP snapped a five-day losing streak on February 2 after strong US ISM Manufacturing Index data showed the sector returning to expansion. The token gained 1.90% that day, closing at $1.6192.

Technical analysis shows XRP trading below its 50-day and 200-day moving averages. Support levels to watch include $1.50 and $1.00. Resistance levels include $1.75, $2.00, and $2.50.

The post XRP Price: Three Factors That Could Trigger a Rebound from Current Levels appeared first on CoinCentral.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29